GLAXOSMITHKLINE PHARMACEUTICALS
Quarterly Results Analysis [Sep2025]
GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Results
| Consolidated | Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹980 Cr | ₹805 Cr | ₹974 Cr | ₹949 Cr | ₹1,011 Cr | ₹815 Cr | ₹930 Cr | ₹805 Cr |
| Expenses | ₹644 Cr | ₹554 Cr | ₹641 Cr | ₹658 Cr | ₹689 Cr | ₹584 Cr | ₹673 Cr | ₹587 Cr |
| Operating Income | ₹336 Cr | ₹251 Cr | ₹333 Cr | ₹292 Cr | ₹322 Cr | ₹231 Cr | ₹257 Cr | ₹218 Cr |
| Other Income | ₹34 Cr | ₹44 Cr | ₹41 Cr | ₹35 Cr | ₹35 Cr | ₹36 Cr | ₹30 Cr | ₹28 Cr |
| Interest | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr |
| Depreciation | ₹17 Cr | ₹16 Cr | ₹15 Cr | ₹19 Cr | ₹17 Cr | ₹16 Cr | ₹18 Cr | ₹17 Cr |
| Profit Before Tax | ₹354 Cr | ₹279 Cr | ₹359 Cr | ₹308 Cr | ₹344 Cr | ₹249 Cr | ₹271 Cr | ₹65 Cr |
| Profit After Tax | ₹257 Cr | ₹205 Cr | ₹263 Cr | ₹230 Cr | ₹253 Cr | ₹182 Cr | ₹194 Cr | ₹46 Cr |
| EPS | ₹15.20 | ₹12.10 | ₹15.52 | ₹13.57 | ₹14.90 | ₹10.76 | ₹11.48 | ₹2.70 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| GLAXOSMITHKLINE PHARMACEUTICALS | 2.2% | 4.2% | 12.7% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.1% | 3.4% | -0.1% |
| DIVIS LABORATORIES | 1.6% | -2.5% | 8.4% |
| CIPLA | 1.3% | -0.6% | 3.9% |
| TORRENT PHARMACEUTICALS | 0.8% | -0.9% | 13.5% |
| DR REDDYS LABORATORIES | 1% | 3.7% | 2.7% |
| MANKIND PHARMA | -0.3% | -3.4% | -18.8% |
| ZYDUS LIFESCIENCES | 0.5% | -1.6% | -5.4% |
| LUPIN | 2.1% | 3% | -2.5% |
GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 21.71 % |
| Y-o-Y | -3.05 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Sep2025 | ₹980 Cr | 21.71 | |
| Jun2025 | ₹805 Cr | -17.37 | |
| Mar2025 | ₹974 Cr | 2.63 | |
| Dec2024 | ₹949 Cr | -6.07 | |
| Sep2024 | ₹1,011 Cr | 24.07 | |
| Jun2024 | ₹815 Cr | -12.38 | |
| Mar2024 | ₹930 Cr | 15.47 | |
| Dec2023 | ₹805 Cr | - | |
GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 33.65 % |
| Y-o-Y | 4.36 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Sep2025 | ₹336 Cr | 33.65 | |
| Jun2025 | ₹251 Cr | -24.61 | |
| Mar2025 | ₹333 Cr | 14.14 | |
| Dec2024 | ₹292 Cr | -9.26 | |
| Sep2024 | ₹322 Cr | 39.55 | |
| Jun2024 | ₹231 Cr | -10.39 | |
| Mar2024 | ₹257 Cr | 17.98 | |
| Dec2023 | ₹218 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 9.81 % |
| Y-o-Y | 7.63 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Sep2025 | 34.26% | 9.81 | |
| Jun2025 | 31.2% | -8.77 | |
| Mar2025 | 34.2% | 11.22 | |
| Dec2024 | 30.75% | -3.39 | |
| Sep2024 | 31.83% | 12.47 | |
| Jun2024 | 28.3% | 2.28 | |
| Mar2024 | 27.67% | 2.18 | |
| Dec2023 | 27.08% | - | |
GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 25.60 % |
| Y-o-Y | 1.98 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Sep2025 | ₹257 Cr | 25.60 | |
| Jun2025 | ₹205 Cr | -22.01 | |
| Mar2025 | ₹263 Cr | 14.35 | |
| Dec2024 | ₹230 Cr | -8.96 | |
| Sep2024 | ₹253 Cr | 38.49 | |
| Jun2024 | ₹182 Cr | -6.25 | |
| Mar2024 | ₹194 Cr | 325.37 | |
| Dec2023 | ₹46 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 3.22 % |
| Y-o-Y | 5.20 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Sep2025 | 26.28 % | 3.22 | |
| Jun2025 | 25.46 % | -5.63 | |
| Mar2025 | 26.98 % | 11.44 | |
| Dec2024 | 24.21 % | -3.08 | |
| Sep2024 | 24.98 % | 11.62 | |
| Jun2024 | 22.38 % | 6.98 | |
| Mar2024 | 20.92 % | 268.31 | |
| Dec2023 | 5.68 % | - | |
GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 25.62 % |
| Y-o-Y | 2.01 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Sep2025 | ₹15.2 | 25.62 | |
| Jun2025 | ₹12.1 | -22.04 | |
| Mar2025 | ₹15.52 | 14.37 | |
| Dec2024 | ₹13.57 | -8.93 | |
| Sep2024 | ₹14.9 | 38.48 | |
| Jun2024 | ₹10.76 | -6.27 | |
| Mar2024 | ₹11.48 | 325.19 | |
| Dec2023 | ₹2.7 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD